Targeting the hallmarks of cancer.
Siddiqa
Aisha
A
Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229, USA.
Marciniak
Robert
R
D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000378:metabolism*; D045744:Cell Line, Tumor; D015972:Gene Expression Regulation, Neoplastic; D020868:Gene Silencing; D015316:Genetic Therapy; D006801:Humans; D007822:Laryngeal Neoplasms / Q000378:metabolism*; D051379:Mice; D008954:Models, Biological; D009368:Neoplasm Transplantation; D034622:RNA Interference; D019098:Telomerase / Q000037:antagonists & inhibitors*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D051020:bcl-X Protein / Q000037:antagonists & inhibitors*
D042461:Vascular Endothelial Growth Factor A; D051020:bcl-X Protein; C509186:TERT protein, human; D019098:Telomerase